Ali A, Saleh M, Yaqoob Q, Saied S, Hasan M, Owaid K
    
    
    J Genet Eng Biotechnol. 2025; 23(1):100452.
  
  
    PMID: 40074426
    
          PMC: 11732482.
    
          DOI: 10.1016/j.jgeb.2024.100452.
      
 
                                  
  
    Nevrlka F, Bedron A, Valenta M, Tranova L, Styskala J
    
    
    ACS Omega. 2024; 9(15):17368-17378.
  
  
    PMID: 38645315
    
          PMC: 11024948.
    
          DOI: 10.1021/acsomega.4c00068.
      
 
                                  
  
    Ray P, Shabana K, Salahuddin , Kumar R
    
    
    Curr Top Med Chem. 2024; 24(10):885-928.
  
  
    PMID: 38500288
    
    
          DOI: 10.2174/0115680266284283240304071648.
      
 
                                  
  
    De S, Kumar S K A, Shah S, Kazi S, Sarkar N, Banerjee S
    
    
    RSC Adv. 2022; 12(24):15385-15406.
  
  
    PMID: 35693235
    
          PMC: 9121228.
    
          DOI: 10.1039/d2ra01571d.
      
 
                                  
  
    Basak P, Dey S, Ghosh P
    
    
    RSC Adv. 2022; 11(51):32106-32118.
  
  
    PMID: 35495527
    
          PMC: 9041786.
    
          DOI: 10.1039/d1ra06331f.
      
 
                              
              
                              
                                      
  Denitrogenative Transformations of Pyridotriazoles and Related Compounds: Synthesis of -Containing Heterocyclic Compounds and Beyond.
  
    Yadagiri D, Rivas M, Gevorgyan V
    
    
    J Org Chem. 2020; 85(17):11030-11046.
  
  
    PMID: 32786635
    
          PMC: 7576888.
    
          DOI: 10.1021/acs.joc.0c01652.
      
 
                                          
                                                          
  An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes.
  
    Bansal G, Thanikachalam P, Maurya R, Chawla P, Ramamurthy S
    
    
    J Adv Res. 2020; 23:163-205.
  
  
    PMID: 32154036
    
          PMC: 7052407.
    
          DOI: 10.1016/j.jare.2020.01.008.
      
 
                                          
                                                          
  L-Proline functionalized magnetic nanoparticles: A novel magnetically reusable nanocatalyst for one-pot synthesis of 2,4,6-triarylpyridines.
  
    Maleki A, Firouzi-Haji R
    
    
    Sci Rep. 2018; 8(1):17303.
  
  
    PMID: 30470821
    
          PMC: 6251865.
    
          DOI: 10.1038/s41598-018-35676-x.
      
 
                                          
                                                          
  Malononitrile dimer as a privileged reactant in design and skeletal diverse synthesis of heterocyclic motifs.
  
    Shaabani A, Hooshmand S
    
    
    Mol Divers. 2018; 22(1):207-224.
  
  
    PMID: 29299856
    
    
          DOI: 10.1007/s11030-017-9807-y.
      
 
                                          
                                                          
  Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks.
  
    Lim S, Kim K, Kim S, Kim D, Woo J, Chung C
    
    
    Diabetes Metab J. 2017; 41(5):377-385.
  
  
    PMID: 29086536
    
          PMC: 5663677.
    
          DOI: 10.4093/dmj.2017.41.5.377.
      
 
                                          
                                                          
  Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice.
  
    Kim K, Jin H, Lee S, Maeng H, Lee G, Oh T
    
    
    Endocrinol Metab (Seoul). 2017; 32(3):389-395.
  
  
    PMID: 28956370
    
          PMC: 5620037.
    
          DOI: 10.3803/EnM.2017.32.3.389.
      
 
                                          
                                                          
  Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.
  
    Laxmi S, Anil P, Rajitha G, Rao A, Crooks P, Rajitha B
    
    
    J Chem Biol. 2016; 9(4):97-106.
  
  
    PMID: 27698947
    
          PMC: 5026645.
    
          DOI: 10.1007/s12154-016-0154-8.
      
 
                                          
                                                          
  Crystal structure of (5-chloro-2-hy-droxy-phen-yl)(3-methyl-isoxazolo[5,4-b]pyridin-5-yl)methanone.
  
    Raja R, Poomathi N, Perumal P, SubbiahPandi A
    
    
    Acta Crystallogr E Crystallogr Commun. 2015; 71(Pt 11):o875-6.
  
  
    PMID: 26594574
    
          PMC: 4645069.
    
          DOI: 10.1107/S2056989015019635.
      
 
                                          
                                                          
  Crystal structure of N-[4-amino-5-cyano-6-(methyl-sulfan-yl)pyridin-2-yl]acetamide hemihydrate.
  
    Akkurt M, Knight K, Mohamed S, Hussein B, Albayati M
    
    
    Acta Crystallogr E Crystallogr Commun. 2015; 71(Pt 3):o171-2.
  
  
    PMID: 25844232
    
          PMC: 4350750.
    
          DOI: 10.1107/S205698901500256X.
      
 
                                          
                                                          
  Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin.
  
    Jung J, Lee S, Kim T, Kim J, Kim C, Huh W
    
    
    Drug Des Devel Ther. 2015; 9:737-43.
  
  
    PMID: 25767371
    
          PMC: 4354432.
    
          DOI: 10.2147/DDDT.S76591.
      
 
                                          
                                                          
  Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.
  
    Jin S, Park C, Cho Y, Ku B, Ahn C, Cha B
    
    
    Diabetes Obes Metab. 2015; 17(6):599-602.
  
  
    PMID: 25580775
    
          PMC: 5024060.
    
          DOI: 10.1111/dom.12435.
      
 
                                          
                                                          
  Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjects.
  
    Park M, Kim T, Kim J, Kim C, Yoon S, Cho J
    
    
    Clin Drug Investig. 2014; 34(7):467-74.
  
  
    PMID: 24802657
    
    
          DOI: 10.1007/s40261-014-0197-y.
      
 
                                          
                                                          
  Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: a multicenter, randomized, double-blind, parallel-group, placebo controlled trial.
  
    Kim S, Kim D, Woo J, Jang H, Chung C, Ko K
    
    
    PLoS One. 2014; 9(4):e92843.
  
  
    PMID: 24736628
    
          PMC: 3988010.
    
          DOI: 10.1371/journal.pone.0092843.
      
 
                                          
                                                          
  Crystal structures and antifungal activities of fluorine-containing thioureido complexes with nickel(II).
  
    Li C, Yang W, Liu H, Li M, Zhou W, Xie J
    
    
    Molecules. 2013; 18(12):15737-49.
  
  
    PMID: 24352026
    
          PMC: 6270642.
    
          DOI: 10.3390/molecules181215737.
      
 
                                          
                                                          
  Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles.
  
    de Farias Santiago E, de Oliveira S, Bezerra de Oliveira Filho G, Moreira D, Gomes P, Silva A
    
    
    Antimicrob Agents Chemother. 2013; 58(1):352-63.
  
  
    PMID: 24165185
    
          PMC: 3910798.
    
          DOI: 10.1128/AAC.01900-13.